Honoring a Legacy: George Edgecomb Society Works to Address Cancer Disparities
Key Takeaways:
- The loss of Judge George Edgecomb, a close friend of Lee Moffitt, helped inspire the creation of Moffitt Cancer Center and its commitment to improving access to cancer care
- Established in 2017, the George Edgecomb Society (GES) works to reduce disparities in cancer incidence, treatment and survival rates among Black communities through research, education, advocacy and community partnerships
- GES has funded 21 pilot research projects targeting cancers that disproportionately affect Black communities, supporting innovative research with the potential to improve patient outcomes
When H. Lee Moffitt was a Florida state representative, he developed a close friendship with George E. Edgecomb, the first African American judge in Hillsborough County.
Just three years after being appointed to the bench, Judge Edgecomb died of leukemia in 1976 at age 33. At the time, local treatment options were limited.
The loss of Judge Edgecomb and other close friends to cancer heavily influenced Moffitt to establish Moffitt Cancer Center, with the goal of improving access to treatment and cancer care in the community.
Growing up, Jennifer Moffitt remembers hearing many stories from her father about Judge Edgecomb.
“I vividly remember hearing my dad talk about the heartbreak of losing Judge Edgecomb,” Jennifer Moffitt said. “My dad often reminisces about their days volunteering together and their shared determination to give back to the community and the Tampa Bay area."
A Mission Takes Shape
Decades after the cancer center opened its doors, eliminating cancer health disparities in communities of color, particularly among African Americans, remains a priority.
That need, along with the strong connection between Moffitt and Judge Edgecomb, led to the creation of the George Edgecomb Society, or GES, in 2017.
Through groundbreaking research, education, advocacy and community partnerships, GES aims to address disparities in cancer incidence, treatment and survival rates affecting Black communities — a goal Doretha Edgecomb knows her husband would be proud of.
“When I learned more about cancer disparities, I knew I needed to be a part of this,” Doretha Edgecomb said. “I know how important it is for us to champion this cause, spread awareness, raise money for research initiatives and continue to move the needle.”
Investing in Research
Lee Green, PhD, a senior member of the Health Outcomes and Behavior Department at Moffitt and a key leader of GES, sees firsthand how research affects cancer treatment and care for patients at Moffitt.
Each year, GES invites researchers and investigators to submit pilot project proposals. Experts review the proposals, and funding is awarded to projects that are innovative, realistic and aligned with the GES mission.
“We see a lot of bright and committed researchers who have enthusiasm and dedication to making a change,” Green said.
Since its inception, GES has funded 21 pilot research projects focused on various areas such as lung cancer, breast cancer, pancreatic cancer, colorectal cancer screening and prostate cancer.
Making Every Mile Count
For the first time, GES will participate in Miles for Moffitt as a team, continuing its efforts to support cancer research and raise awareness.
“We decided to name the team the Edgecomb Express, with the idea of all of us rallying together and making a charge against health disparities,” Jennifer Moffitt said.
With the overall goal of making an impact and raising money for cancer research, everyone participating in Miles for Moffitt also has a personal “why.”
Valerie Goddard, a member of Moffitt’s Hospital Board and Institute Board of Directors and one of the founding members of GES, lost her niece, Lisa, to breast cancer at age 40.
“She was a Navy veteran and a mother of two,” Goddard said. “Breast cancer is one of many cancers that disproportionately impacts African Americans. Supporting research and what GES does really hits home because it’s work that can potentially change the outcomes for other people facing a diagnosis like Lisa.”
The Miles for Moffitt fundraising goal for the Edgecomb Express is $50,000. The team chose to start with an ambitious goal and plans to raise it in the years to come.
The race fundraising goal is not the only thing GES aims to increase in the future.
“Right now, our research grants are $100,000 for each project, and we would like to increase that amount to $150,000 down the line,” Green said. “The more we can support the researchers, the more they can do to try and make changes, and we really feel like we are just scratching the surface right now with all we aim to do.”
For those interested, there is still time to support the Edgecomb Express at Miles for Moffitt or join the team and participate on Nov. 21.